Seeking AlphaCodex · 实盘不做把握 5/10🔁 +1 同一事件
北京时间·🕒 发布 05:03:18时区推断·⟳ 抓取 05:06:45·⚡ 决策 07-28 05:08:04 +1m19s·91.6 天前
Brown & Brown二季度调整后EPS符合预期但收入低于预期
本次为排期内盘后财报披露，调整后EPS 1.07美元基本符合预期，收入16.8亿美元低于预期约4000万美元。
📄 原文Seeking Alpha↗ 原文
Brown & Brown Non-GAAP EPS of $1.07 in-line, revenue of $1.68B misses by $40M
For the six months ended June 30, 2026, the Company achieved: - Total revenues of $3.6 billion, increasing $888 million…
不做 Brown & Brown（BRO.US）
财报为排期内披露，EPS基本符合预期但收入小幅miss、内生增长偏弱，正负信息混合且缺少明确指引下修或超预期增量；不追多，也不满足强空催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- 公司提前公告将于2026-07-27盘后发布二季度业绩，财报日期本身不是新催化。
- 媒体披露二季度调整后EPS 1.07美元符合预期、收入16.8亿美元低于预期4000万美元。市场反应:事件发生在美股收盘后，连续交易已结束。
关键理由
- 本次为排期内盘后财报披露，调整后EPS 1.07美元基本符合预期，收入16.8亿美元低于预期约4000万美元。
- 半年口径总收入同比增长33%，但Organic Revenue下降0.3%，说明并购贡献强于内生增长，短线方向不够干净。
- 保险经纪大市值标的财报类催化默认需要明确超预期或指引上修，本条没有形成足够正向或负向交易边界。
主要风险
- 收入miss和有机收入下滑可能压制估值，但EPS符合预期且利润同比增长，净利空强度不足以单独触发可执行做空。
- 财报电话会在2026-07-28 08:00 ET，管理层指引或并购整合细节可能改变市场解读。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-07-27 · 影响 weakens
收入低于预期且Organic Revenue下降0.3%，削弱财报追多依据。
检索:Brown & Brown Q2 2026 earnings revenue miss organic revenue decline 原文 ↗ - 做空前查反向 · 来源 web · 日期 2026-07-27 · 影响 weakens
调整后EPS基本符合预期、半年净利润同比增长26.8%，不足以构成强空催化。
检索:Brown & Brown Q2 2026 adjusted EPS in line net income growth 原文 ↗
原文全文
展开原文 · 868 字
For the six months ended June 30, 2026, the Company achieved:
- Total revenues of $3.6 billion, increasing $888 million, or 33.0%, compared to the same period in 2025, with Organic Revenue decreasing 0.3% and Organic Revenue with Contingents increasing 1.6%.
- Income before income taxes of $915 million, increasing 24.0%, with Income Before Income Taxes Margin of 25.6%, compared to 27.4% in the same period in 2025.
- EBITDAC - Adjusted of $1.3 billion, increasing 32.2%, with EBITDAC Margin - Adjusted of 37.2%, compared to 37.4% in the same period in 2025.
- Net income attributable to the Company of $714 million, increasing $151 million, or 26.8%, compared to the same period in 2025.
- Diluted net income per share of $1.90, a decrease of 1.6%, with Diluted Net Income Per Share - Adjusted increasing to $2.46, or 6.0%, each compared to the same period in 2025.
- Total revenues of $3.6 billion, increasing $888 million, or 33.0%, compared to the same period in 2025, with Organic Revenue decreasing 0.3% and Organic Revenue with Contingents increasing 1.6%.
- Income before income taxes of $915 million, increasing 24.0%, with Income Before Income Taxes Margin of 25.6%, compared to 27.4% in the same period in 2025.
- EBITDAC - Adjusted of $1.3 billion, increasing 32.2%, with EBITDAC Margin - Adjusted of 37.2%, compared to 37.4% in the same period in 2025.
- Net income attributable to the Company of $714 million, increasing $151 million, or 26.8%, compared to the same period in 2025.
- Diluted net income per share of $1.90, a decrease of 1.6%, with Diluted Net Income Per Share - Adjusted increasing to $2.46, or 6.0%, each compared to the same period in 2025.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。